Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 3,697 | 79 | 254 |
| Receivables | 245 | 73 | 174 |
| Inventories | 44 | 21 | 48 |
| TOTAL | $4,266 | $243 | $477 |
| Non-Current Assets | |||
| PPE Net | 90 | 89 | 88 |
| Intangibles | 97 | 108 | 78 |
| Other Non-Current Assets | 305 | 70 | 838 |
| TOTAL | $491 | $267 | $1,004 |
| Total Assets | $4,758 | $510 | $1,481 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 597 | 1,204 | 1,592 |
| Accrued Expenses | 1,578 | 401 | 834 |
| Other current liabilities | 42 | 83 | 4,029 |
| TOTAL | $2,433 | $1,886 | $6,978 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 257 | 27 | 76 |
| TOTAL | $257 | $27 | $76 |
| Total Liabilities | $2,690 | $1,913 | $7,054 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 7,216 | 6,595 | N/A |
| Common Shares | 7 | 7 | 2 |
| Retained earnings | -56,800 | -48,558 | -33,931 |
| Other shareholders' equity | 4 | 0 | 1 |
| TOTAL | $2,068 | $-1,403 | $-5,574 |
| Total Liabilities And Equity | $4,758 | $510 | $1,481 |